Kezar Life Sciences Inc (KZR) Up 10.53% in Premarket Trading

Kezar Life Sciences Inc (KZR) has gained Thursday morning, with the stock increasing 10.53% in pre-market trading to 1.26. KZR's short-term technical score of 12 indicates that the stock has traded less bullishly over the last month than 88% of stocks on the market. In the Biotechnology industry, which ranks 131 out of 146 industries, the stock ranks higher than 24% of stocks. Kezar Life Sciences Inc has fallen 10.94% over the past month, closing at $1.50 on August 24. During this period of time, the stock fell as low as $1.19 and as high as $1.69. KZR has an average analyst recommendation of Strong Buy. The company has an average price target of $12.33.

KZR has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on KZR!

See Full KZR Report

Kezar Life Sciences Inc has a Long-Term Technical rank of 6. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 94% of the market scoring higher. In the Biotechnology industry which is number 137 by this metric, KZR ranks better than 137% of stocks.

Important Dates for Investors in KZR:

-Kezar Life Sciences Inc is set to release earnings on 2023-11-09. Over the last 12 months, the company has reported EPS of $-1.15. -We do not have a set dividend date for Kezar Life Sciences Inc at this time. Click Here To Get The Full Report on Kezar Life Sciences Inc (KZR)